|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-3-26
|
|
pubmed:abstractText |
Up to 37% of patients undergoing MR imaging examinations experience moderate to severe levels of anxiety that necessitate the termination of the procedure in 5-10% of patients. Although the clinical use of MR imaging has increased, effective procedures to handle claustrophobia are lacking. We evaluated the effectiveness of intranasally administered midazolam spray in preventing claustrophobic responses of patients undergoing MR imaging.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0361-803X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
176
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
865-8
|
|
pubmed:dateRevised |
2008-2-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11264066-Administration, Intranasal,
pubmed-meshheading:11264066-Adult,
pubmed-meshheading:11264066-Arousal,
pubmed-meshheading:11264066-Conscious Sedation,
pubmed-meshheading:11264066-Double-Blind Method,
pubmed-meshheading:11264066-Female,
pubmed-meshheading:11264066-Humans,
pubmed-meshheading:11264066-Magnetic Resonance Imaging,
pubmed-meshheading:11264066-Male,
pubmed-meshheading:11264066-Midazolam,
pubmed-meshheading:11264066-Middle Aged,
pubmed-meshheading:11264066-Panic,
pubmed-meshheading:11264066-Patient Acceptance of Health Care,
pubmed-meshheading:11264066-Phobic Disorders,
pubmed-meshheading:11264066-Prospective Studies
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Using intranasal midazolam spray to prevent claustrophobia induced by MR imaging.
|
|
pubmed:affiliation |
Department of Anaesthesiology, Medical School of Hannover, Carl-Neuberg-Str. 1, 30625 Hannover, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
